This website uses cookies

We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will only use cookies based on your decision.

Ligand key visual

Creating a Theranostics ProgramHow do you find the personalized support you need to create, build, equip, 
and finance your theranostics program?

Novel radioligand diagnostics and therapies for conditions like Neuroendocrine and Prostate Cancer are on the rise, making patient access to this new oncology service more critical than ever. With a host of clinical trials in this emerging space, the demand for theranostics is set to grow even further with new diagnostic and treatment indications.   

To effectively deliver theranostics solutions to your patients, you’ll need specific types of support. Here’s what to consider. 


Pages from the case study

In this case study, Steve Wozniak, Associate Director of Molecular Imaging & Theranostics, and Andrew Moran, MD, Chief Radiologist of Nuclear Medicine at 210 PET Imaging, share their learnings and recommendations for other providers. Read what they have to say about building a theranostics program.

Please complete the form below to be included in future email communications

By completing the form below, you are requesting to be added to our list for email communications. The information you provide below will be processed as described further in the privacy policy.

*Required

1
Subscription Button Icon
Be the first to know about our events, training, and news